Akehi, Y., Yanase, T., Motonaga, R., Umakoshi, H., Tsuiki, M., Takeda, Y., Yoneda, T., Kurihara, I., Itoh, H., Katabami, T., et al. (2019). High Prevalence of Diabetes in Patients With Primary Aldosteronism (PA) Associated With Subclinical Hypercortisolism and Prediabetes More Prevalent in Bilateral Than Unilateral PA: A Large, Multicenter Cohort Study in Japan. Diabetes Care 42, 938-945.
Backer, J.M. (2008). The regulation and function of Class III PI3Ks: novel roles for Vps34. Biochem. J. 410, 1-17.
Bellingham, D.L., Sar, M., and Cidlowski, J.A. (1992). Ligand-dependent down-regulation of stably transfected human glucocorticoid receptors is associated with the loss of functional glucocorticoid responsiveness. Mol. Endocrinol. 6, 2090-2102.
Beurel, E., Grieco, S.F., and Jope, R.S. (2015). Glycogen synthase kinase-3 (GSK3): regulation, actions, and diseases. Pharmacol. Ther. 148, 114-131.
Caprio, M., Fève, B., Claës, A., Viengchareun, S., Lombès, M., and Zennaro, M.C. (2007). Pivotal role of the mineralocorticoid receptor in corticosteroid-induced adipogenesis. Faseb.j. 21, 2185-2194.
Chen, W., Dang, T., Blind, R.D., Wang, Z., Cavasotto, C.N., Hittelman, A.B., Rogatsky, I., Logan, S.K., and Garabedian, M.J. (2008). Glucocorticoid receptor phosphorylation differentially affects target gene expression. Mol. Endocrinol. 22, 1754-1766.
Chiang, B.N., Perlman, L.V., and Epstein, F.H. (1969). Overweight and hypertension. A review. Circulation 39, 403-421.
Cunningham, J.T., Rodgers, J.T., Arlow, D.H., Vazquez, F., Mootha, V.K., and Puigserver, P. (2007). mTOR controls mitochondrial oxidative function through a YY1-PGC-1alpha transcriptional complex. Nature 450, 736-740.
Deng, J., Guo, Y., Yuan, F., Chen, S., Yin, H., Jiang, X., Jiao, F., Wang, F., Ji, H., Hu, G., et al. (2020). Autophagy inhibition prevents glucocorticoid-increased adiposity via suppressin. BAT whitening. Autophagy 16, 451-465.
Devereaux, K., Dall'Armi, C., Alcazar-Roman, A., Ogasawara, Y., Zhou, X., Wang, F., Yamamoto, A., De Camilli, P., and Di Paolo, G. (2013). Regulation of mammalian autophagy by class II and III PI 3-kinases through PI3P synthesis. PLoS. One 8, e76405.
Ehrhart-Bornstein, M., Lamounier-Zepter, V., Schraven, A., Langenbach, J., Willenberg, H.S., Barthel, A., Hauner, H., McCann, S.M., Scherbaum, W.A., and Bornstein, S.R. (2003). Human adipocytes secrete mineralocorticoid-releasing factors. Proc. Natl. Acad. Sci. U S A. 100, 14211-14216.
Engeli, S., Böhnke, J., Gorzelniak, K., Janke, J., Schling, P., Bader, M., Luft, F.C., and Sharma, A.M. (2005). Weight loss and the renin-angiotensin-aldosterone system.Hypertension 45, 356-362.
Esteves, C.L., Kelly, V., Bégay, V., Man, T.Y., Morton, N.M., Leutz, A., Seckl, J.R., and Chapman, K.E. (2012). Regulation of adipocyte 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) by CCAAT/enhancer-binding protein (C/EBP) β isoforms, LIP and LAP. PLoS. One 7, e37953.
Garg, R., Hurwitz, S., Williams, G.H., Hopkins, P.N., and Adler, G.K. (2010). Aldosterone production and insulin resistance in healthy adults. J. Clin. Endocrinol. Metab. 95, 1986- 1990.
Grøntved, L., John, S., Baek, S., Liu, Y., Buckley, J.R., Vinson, C., Aguilera, G., and Hager.G.L. (2013). C/EBP maintains chromatin accessibility in liver and facilitates glucocorticoid receptor recruitment to steroid response elements. Embo. j. 32, 1568-1583.
Hannemann, A., and Wallaschofski, H. (2012). Prevalence of primary aldosteronism in patient's cohorts and in population-based studies--a review of the current literature. Horm. Metab. Res. 44, 157-162.
Hanslik, G., Wallaschofski, H., Dietz, A., Riester, A., Reincke, M., Allolio, B., Lang, K., Quack, I., Rump, L.C., Willenberg, H.S., et al. (2015). Increased prevalence of diabetes mellitus and the metabolic syndrome in patients with primary aldosteronism of the German Conn's Registry. Eur. J. Endocrinol. 173, 665-675.
He, B., Cruz-Topete, D., Oakley, R.H., Xiao, X., and Cidlowski, J.A. (2015). Huma.Glucocorticoid Receptor β Regulates Gluconeogenesis and Inflammation in Mouse Liver.Mol. Cell. Biol. 36, 714-730.
Hermida, M.A., Dinesh Kumar, J., and Leslie, N.R. (2017). GSK3 and its interactions with the PI3K/AKT/mTOR signalling network. Adv. Biol. Regul. 65, 5-15.
Hinds, T.D., Jr., Ramakrishnan, S., Cash, H.A., Stechschulte, L.A., Heinrich, G., Najjar, S.M., and Sanchez, E.R. (2010). Discovery of glucocorticoid receptor-beta in mice with a role in metabolism. Mol. Endocrinol. 24, 1715-1727.
Hollenberg, S.M., Weinberger, C., Ong, E.S., Cerelli, G., Oro, A., Lebo, R., Thompson, E.B., Rosenfeld, M.G., and Evans, R.M. (1985). Primary structure and expression of a functional human glucocorticoid receptor cDNA. Nature 318, 635-641.
Huang, X., Liu, G., Guo, J., and Su, Z. (2018). The PI3K/AKT pathway in obesity and type 2 diabetes. Int. J. Biol. Sci. 14, 1483-1496.
Huby, A.C., Antonova, G., Groenendyk, J., Gomez-Sanchez, C.E., Bollag, W.B., Filosa, J.A., and Belin de Chantemèle, E.J. (2015). Adipocyte-Derived Hormone Leptin Is a Direct Regulator of Aldosterone Secretion, Which Promotes Endothelial Dysfunction and Cardiac Fibrosis. Circulation 132, 2134-2145.
Hughes, M.L., Liu, B., Halls, M.L., Wagstaff, K.M., Patil, R., Velkov, T., Jans, D.A., Bunnett, N.W., Scanlon, M.J., and Porter, C.J. (2015). Fatty Acid-binding Proteins 1 and 2 Differentially Modulate the Activation of Peroxisome Proliferator-activated Receptor α in a Ligand-selective Manner. J. Biol. Chem. 290, 13895-13906.
Iershov, A., Nemazanyy, I., Alkhoury, C., Girard, M., Barth, E., Cagnard, N., Montagner, A., Chretien, D., Rugarli, E.I., Guillou, H., et al. (2019). The class 3 PI3K coordinates autophagy and mitochondrial lipid catabolism by controlling nuclear receptor PPARα. Nat. Commun. 10, 1566.
Jeon, J.H., Kim, K.Y., Kim, J.H., Baek, A., Cho, H., Lee, Y.H., Kim, J.W., Kim, D., Han.S.H., Lim, J.S., et al. (2008). A novel adipokine CTRP1 stimulates aldosterone production.Faseb. j. 22, 1502-1511.
Kadmiel, M., and Cidlowski, J.A. (2013). Glucocorticoid receptor signaling in health and disease. Trends Pharmacol. Sci. 34, 518-530.
Kang, K.I., Meng, X., Devin-Leclerc, J., Bouhouche, I., Chadli, A., Cadepond, F., Baulieu, E.E., and Catelli, M.G. (1999). The molecular chaperone Hsp90 can negatively regulate the activity of a glucocorticosteroid-dependent promoter. Proc. Natl. Acad. Sci. U S A. 96, 1439- 1444.
Kargi, A.Y., and Iacobellis, G. (2014). Adipose tissue and adrenal glands: novel pathophysiological mechanisms and clinical applications. Int. J. Endocrinol. 2014, 614074.
Kinyamu, H.K., and Archer, T.K. (2003). Estrogen receptor-dependent proteasomal degradation of the glucocorticoid receptor is coupled to an increase in mdm2 protein expression. Mol. Cell. Biol. 23, 5867-5881.
Kirschke, E., Goswami, D., Southworth, D., Griffin, P.R., and Agard, D.A. (2014). Glucocorticoid receptor function regulated by coordinated action of the Hsp90 and Hsp70 chaperone cycles. Cell 157, 1685-1697.
Kuo, T., Lew, M.J., Mayba, O., Harris, C.A., Speed, T.P., and Wang, J.C. (2012). Genome- wide analysis of glucocorticoid receptor-binding sites in myotubes identifies gene networks modulating insulin signaling. Proc. Natl. Acad. Sci. U S A. 109, 11160-11165.
Laplante, M., and Sabatini, D.M. (2013). Regulation of mTORC1 and its impact on gene expression at a glance. J. Cell. Sci. 126, 1713-1719.
Leis, H., Page, A., Ramírez, A., Bravo, A., Segrelles, C., Paramio, J., Barettino, D., Jorcano, J.L., and Pérez, P. (2004). Glucocorticoid Receptor Counteracts Tumorigenic Activity of Akt in Skin through Interference with the Phosphatidylinositol 3-Kinase Signaling Pathway.Mol. Endocrinol. 18, 303-311.
Licata, G., Scaglione, R., Ganguzza, A., Corrao, S., Donatelli, M., Parrinello, G., Dichiara, M.A., Merlino, G., and Cecala, M.G. (1994). Central obesity and hypertension. Relationship between fasting serum insulin, plasma renin activity, and diastolic blood pressure in youn.obese subjects. Am. J. Hypertens. 7, 314-320.
Luther, J.M. (2014). Effects of aldosterone on insulin sensitivity and secretion. Steroids 91, 54-60.
Martelli, A.M., Tabellini, G., Bressanin, D., Ognibene, A., Goto, K., Cocco, L., and Evangelisti, C. (2012). The emerging multiple roles of nuclear Akt. Biochim. Biophys. Acta. 1823, 2168-2178.
Marzolla, V., Armani, A., Zennaro, M.C., Cinti, F., Mammi, C., Fabbri, A., Rosano, G.M., and Caprio, M. (2012). The role of the mineralocorticoid receptor in adipocyte biology and fat metabolism. Mol. Cell. Endocrinol. 350, 281-288.
Matrozova, J., Steichen, O., Amar, L., Zacharieva, S., Jeunemaitre, X., and Plouin, P.F. (2009). Fasting plasma glucose and serum lipids in patients with primary aldosteronism: a controlled cross-sectional study. Hypertension 53, 605-610.
Monticone, S., D'Ascenzo, F., Moretti, C., Williams, T.A., Veglio, F., Gaita, F., and Mulatero.P. (2018). Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: a systematic review and meta-analysis. Lancet Diabetes Endocrinol. 6, 41-50.
Monticone, S., Viola, A., Rossato, D., Veglio, F., Reincke, M., Gomez-Sanchez, C., and Mulatero, P. (2015). Adrenal vein sampling in primary aldosteronism: towards a standardised protocol. Lancet Diabetes Endocrinol. 3, 296-303.
Nemazanyy, I., Montagnac, G., Russell, R.C., Morzyglod, L., Burnol, A.F., Guan, K.L., Pende, M., and Panasyuk, G. (2015). Class III PI3K regulates organismal glucose homeostasis by providing negative feedback on hepatic insulin signalling. Nat. Commun. 6, 8283.
Nicklas, B.J., Penninx, B.W., Ryan, A.S., Berman, D.M., Lynch, N.A., and Dennis, K.E. (2003). Visceral adipose tissue cutoffs associated with metabolic risk factors for coronary heart disease in women. Diabetes Care 26, 1413-1420.
Nishikawa, T., Omura, M., Satoh, F., Shibata, H., Takahashi, K., Tamura, N., and Tanabe.A. (2011). Guidelines for the diagnosis and treatment of primary aldosteronism--the Japan Endocrine Society 2009. Endocr. J. 58, 711-721.
Omura, M., Sasano, H., Saito, J., Yamaguchi, K., Kakuta, Y., and Nishikawa, T. (2006). Clinical characteristics of aldosterone-producing microadenoma, macroadenoma, and idiopathic hyperaldosteronism in 93 patients with primary aldosteronism. Hypertens. Res. 29, 883-889.
Panaretou, C., Domin, J., Cockcroft, S., and Waterfield, M.D. (1997). Characterization of p150, an adaptor protein for the human phosphatidylinositol (PtdIns) 3-kinase. Substrate presentation by phosphatidylinositol transfer protein to the p150.Ptdins 3-kinase complex.J. Biol. Chem. 272, 2477-2485.
Patt, M., Gysi, J., Faresse, N., Cidlowski, J.A., and Odermatt, A. (2020). Protein phosphatase 1 alpha enhances glucocorticoid receptor activity by a mechanism involving phosphorylation of serine-211. Mol. Cell. Endocrinol. 518, 110873.
Piovan, E., Yu, J., Tosello, V., Herranz, D., Ambesi-Impiombato, A., Da Silva, A.C., Sanchez- Martin, M., Perez-Garcia, A., Rigo, I., Castillo, M., et al. (2013). Direct reversal of glucocorticoid resistance by AKT inhibition in acute lymphoblastic leukemia. Cancer Cell 24, 766-776.
Rossi, G.P., Sacchetto, A., Chiesura-Corona, M., De Toni, R., Gallina, M., Feltrin, G.P., and Pessina, A.C. (2001). Identification of the etiology of primary aldosteronism with adrenal vein sampling in patients with equivocal computed tomography and magnetic resonance findings: results in 104 consecutive cases. J. Clin. Endocrinol. Metab. 86, 1083-1090.
Rossi, G.P., Sticchi, D., Giuliani, L., Bernante, P., Zavattiero, S., Pessina, A.C., and Nussdorfer, G.G. (2006). Adiponectin receptor expression in the human adrenal cortex and aldosterone-producing adenomas. Int. J. Mol. Med. 17, 975-980.
Satoh, F., Morimoto, R., Seiji, K., Satani, N., Ota, H., Iwakura, Y., Ono, Y., Kudo, M., Nezu, M., Omata, K., et al. (2015). Is there a role for segmental adrenal venous sampling and adrenal sparing surgery in patients with primary aldosteronism? Eur. J. Endocrinol. 173, 465-477.Seckl, J.R., and Walker, B.R. (2001). Minireview: 11beta-hydroxysteroid dehydrogenase type 1- a tissue-specific amplifier of glucocorticoid action. Endocrinology 142, 1371-1376.
Sengupta, S., and Wasylyk, B. (2001). Ligand-dependent interaction of the glucocorticoid receptor with p53 enhances their degradation by Hdm2. Genes Dev. 15, 2367-2380.
Shibayama, Y., Wada, N., Naruse, M., Kurihara, I., Ito, H., Yoneda, T., Takeda, Y., Umakoshi, H., Tsuiki, M., Ichijo, T., et al. (2018). The Occurrence of Apparent Bilateral Aldosterone Suppression in Adrenal Vein Sampling for Primary Aldosteronism. J. Endocr. Soc. 2, 398-407.
Shibayama, Y., Wada, N., Umakoshi, H., Ichijo, T., Fujii, Y., Kamemura, K., Kai, T., Sakamoto, R., Ogo, A., Matsuda, Y., et al. (2016). Bilateral aldosterone suppression and its resolution in adrenal vein sampling of patients with primary aldosteronism: analysis of data from the WAVES-J study. Clin. Endocrinol. (Oxf) 85, 696-702.
Shimamoto, K., Ando, K., Fujita, T., Hasebe, N., Higaki, J., Horiuchi, M., Imai, Y., Imaizumi, T., Ishimitsu, T., Ito, M., et al. (2014). The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2014). Hypertens. Res. 37, 253-390.
Stechschulte, L.A., Wuescher, L., Marino, J.S., Hill, J.W., Eng, C., and Hinds, T.D., Jr.(2014). Glucocorticoid receptor β stimulates Akt1 growth pathway by attenuation of PTEN.J. Biol. Chem. 289, 17885-17894.
Taipale, M., Jarosz, D.F., and Lindquist, S. (2010). HSP90 at the hub of protein homeostasis: emerging mechanistic insights. Nat. Rev. Mol. Cell. Biol. 11, 515-528.
Troncoso, R., Paredes, F., Parra, V., Gatica, D., Vásquez-Trincado, C., Quiroga, C., Bravo- Sagua, R., López-Crisosto, C., Rodriguez, A.E., Oyarzún, A.P., et al. (2014). Dexamethasone- induced autophagy mediates muscle atrophy through mitochondrial clearance. Cell Cycle 13, 2281-2295.
Vandevyver, S., Dejager, L., and Libert, C. (2012). On the trail of the glucocorticoid receptor: into the nucleus and back. Traffic 13, 364-374.
Webb, R., Mathur, A., Chang, R., Baid, S., Nilubol, N., Libutti, S.K., Stratakis, C.A., an.Kebebew, E. (2012). What is the best criterion for the interpretation of adrenal vein sample results in patients with primary hyperaldosteronism? Ann. Surg. Oncol. 19, 1881-1886.
Williams, L.J., Lyons, V., MacLeod, I., Rajan, V., Darlington, G.J., Poli, V., Seckl, J.R., and Chapman, K.E. (2000). C/EBP regulates hepatic transcription of 11beta -hydroxysteroid dehydrogenase type 1. A novel mechanism for cross-talk between the C/EBP and glucocorticoid signaling pathways. J. Biol. Chem. 275, 30232-30239.
Xia, X., Kar, R., Gluhak-Heinrich, J., Yao, W., Lane, N.E., Bonewald, L.F., Biswas, S.K., Lo, W.K., and Jiang, J.X. (2010). Glucocorticoid-induced autophagy in osteocytes. J. Bone.Miner. Res. 25, 2479-2488.
Young, W.F. (2007). Primary aldosteronism: renaissance of a syndrome. Clin. Endocrinol. (Oxf) 66, 607-618.
Young, W.F., Stanson, A.W., Thompson, G.B., Grant, C.S., Farley, D.R., and van Heerden.J.A. (2004). Role for adrenal venous sampling in primary aldosteronism. Surgery 136, 1227- 1235.
Zhou, X., Zhong, Y., Molinar-Inglis, O., Kunkel, M.T., Chen, M., Sun, T., Zhang, J., Shyy, J.Y., Trejo, J., Newton, A.C., et al. (2020). Location-specific inhibition of Akt reveals regulation of mTORC1 activity in the nucleus. Nat. Commun. 11, 6088.
論文の公開元へ
